ข่าวประชาสัมพันธ์
Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
…go: http://www.newscom.com/cgi-bin/prnh/20090727/DE51612LOGO )SOURCE: Eli Lilly and CompanyCONTACT: Tony Hesby or Ryan Giese of BioMS Medical Corp.,Office: +1-780-413-7152,Fax: +1-780-408-3040,E-mail: [email protected]…